The AI-driven biotech has secured FDA alignment on a pivotal trial for its FAP therapy, with a study start planned for 2027.
The "Subject B" exam, which consists of 20 questions to be solved in 100 minutes, significantly impacts whether you pass or ...
In 2023, I wrote an article about speeding up Python calculations with functools.cache. The execution time at the time went from 8.392 seconds to 0.188 milliseconds. That is a difference of about ...
Good morning, everyone, and thank you for joining Recursion's Third Quarter Earnings Call. We're hosting earnings live from the CGA-IGC Annual Meeting in Denver. Today, we'll share the new FAP data ...
Recursion’s Q3 2026 earnings call highlighted REC-4881 FAP data, REC-1245 tumor responses, $749 million in pro forma cash and runway into 2029.
New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden ...
Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results